EMAIL THIS PAGE TO A FRIEND

Journal of orthopaedic research : official publication of the Orthopaedic Research Society

Effect of isolated hyperglycemia on native mechanical and biologic shoulder joint properties in a rat model.


PMID 25070655

Abstract

Recently, diabetes has been linked to rotator cuff disease and adhesive capsulitis, conditions with increased stiffness and inflammation. Unfortunately, limited research exists examining how hyperglycemia affects the native shoulder (tendon and capsule) properties. Therefore, the objectives of this study were to compare shoulder joint mechanics, tendon properties (mechanics and immunohistochemistry), and capsule of healthy control and hyperglycemic rats 8 weeks following induction of hyperglycemia with a submaximal dose of streptozotocin (STZ). Eighteen rats were injected with STZ to induce hyperglycemia or citrate buffer (control) and underwent normal cage activity for 8 weeks. Passive joint mechanics demonstrated significantly less external rotation in the hyperglycemic group compared to controls, with no other group differences. Tendon mechanical properties (stiffness and modulus) were not significantly different between groups at both the insertion site and mid-substance. Immunohistochemistry staining of the tendon and capsule demonstrated significantly increased interleukin 1-beta (IL1-β) and advanced glycated end-products (AGE) staining localized to the insertion and mid-substance of the tendon but not the capsule. In addition, tumor necrosis factor alpha (TNF-α) staining was significantly increased in the superior capsule but not the supraspinatus tendon. This study demonstrates that isolated hypergylcemia does not diminish shoulder mechanical properties but does induce a chronic inflammatory response.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1412741
Anti-RENBP antibody produced in mouse, purified immunoglobulin, 1 mg/mL
HPA000428
Anti-RENBP antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA000522
Anti-RENBP antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4502982
Anti-TNFA antibody produced in rabbit, affinity isolated antibody
T0813 Anti-Tumor Necrosis Factor-α antibody produced in goat, affinity isolated antibody, lyophilized powder
T1816 Anti-Tumor Necrosis Factor-α antibody produced in goat, affinity isolated antibody, lyophilized powder
T0938 Anti-Tumor Necrosis Factor-α antibody produced in goat, affinity isolated antibody, lyophilized powder
T8300
Anti-Tumor Necrosis Factor-α antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
WH0007124M2
Monoclonal Anti-TNF antibody produced in mouse, clone 1C3-A1-F4, purified immunoglobulin, buffered aqueous solution
SAB1404480
Monoclonal Anti-TNF antibody produced in mouse, clone M1-C4, purified immunoglobulin, buffered aqueous solution
T3198 Monoclonal Anti-Tumor Necrosis Factor-α antibody produced in mouse, clone 45418.111, purified immunoglobulin, lyophilized powder
T6817 Monoclonal Anti-Tumor Necrosis Factor-α antibody produced in mouse, clone 28401, purified immunoglobulin, lyophilized powder